FDA label
What is tiagabine used for?
The FDA-approved uses of tiagabine, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Tiagabine hydrochloride tablet is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted tiagabine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Tiagabine Hydrochloride, tablet
Indications and Usage, quoted from the label by Novadoz Pharmaceuticals LLC (ANDA214816). Cross-references to other label sections are left out.
Tiagabine hydrochloride tablet is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures.
Source: DailyMed label, set id 7c034fe0-cdac-49e1-8e39-592846ea3bec, version 1, effective March 1, 2021. NDC 72205-084, one of 4 listings for this product.
Questions
What is tiagabine used for?
The FDA label says: “Tiagabine hydrochloride tablet is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures.”
What drug class is tiagabine?
FDA lists tiagabine in the Anti-epileptic Agent established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.